-
cds.ahrq.gov/sites/default/files/cds/artifact/396/cap_3_DecidExecut.html
January 01, 1970 - to an ICU or high-level monitoring unit is recommended for patients with 3 of the minor criteria for severe … CAP listed in table 4 IF Decidable Vocab patients with 3 of the minor criteria for severe
-
cds.ahrq.gov/sites/default/files/cds/artifact/396/cap_4_DecVars.html
July 25, 2018 - Rec_2: Cond_2: DV_3 patients with 3 of the minor criteria for severe CAP Rec_2: Cond_3: DV_4 when the
-
cds.ahrq.gov/sites/default/files/cds/artifact/396/cap_2_FirstPass%20.html
November 01, 2016 - to an ICU or high-level monitoring unit is recommended for patients with 3 of the minor criteria for severe … listed in table 4 {Rec_2:Cond_ 3 } Decision Variable: patients with 3 of the minor criteria for severe
-
cds.ahrq.gov/sites/default/files/cds/artifact/396/cap_1_Recommendations.html
January 01, 1970 - to an ICU or high-level monitoring unit is recommended for patients with 3 of the minor criteria for severe
-
cds.ahrq.gov/sites/default/files/workgroups/27826/CDS_Connect_WG_Summary_July_2021.pdf
January 01, 2021 - In addition to its recommendations about treatment and prescription updates for mild, moderate, and severe … semistructured decision-making knowledge, taking the
form of escalating steps of care to control progressively severe
-
cds.ahrq.gov/taxonomy/term/37701
February 18, 2019 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/cdsconnect/keywords/disease-severity-score
July 20, 2018 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/106/AMIA_presentation.pptx
January 01, 2012 - Prevalence, Disparities, and Trends in Obesity and Severe Obesity Among Students in the Philadelphia,
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
January 01, 2003 - ML / Sodium Hyaluronate 30 MG/ML Prefilled Syringe F32.2 Major depressive disorder, single episode, severe … Sodium Hyaluronate 10 MG/ML Prefilled Syringe) } Pack F32.3 Major depressive disorder, single episode, severe … MG / Collagen 400 MG / Hyaluronic Acid 40 MG Oral Capsule F33.2 Major depressive disorder, recurrent severe … Sulfates 300 MG / Glucosamine Sulfate 375 MG Oral Capsule F33.3 Major depressive disorder, recurrent, severe … Aluminum Hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML Oral Suspension
E66.2 Morbid (severe
-
cds.ahrq.gov/sites/default/files/workgroups/27826/CDS_Connect_WG_Slides_July_2021.pdf
January 01, 2021 - Recommendations
• E.g., Recommendation #12 (L1)
► “In individuals aged 4 y and older with moderate to severe
-
cds.ahrq.gov/sites/default/files/workgroups/1266/CDS_Connect_April2021_WG_Meeting_Slides.pdf
April 01, 2021 - a cross-sectional study
• Effect of Hydrocortisone on Mortality and Organ Support in Patients with Severe
-
cds.ahrq.gov/taxonomy/term/57436
February 26, 2019 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
January 01, 2017 - .
· Severe liver disease – can be characterized by Active Cirrhosis.
-
cds.ahrq.gov/sites/default/files/cds/artifact/171/Occupational%20Factors%20which%20Impact%20Diabetes,%20%20A%20Final%20Knowledge%20Resource%20Report%20(2015).pdf
January 01, 2015 - Hypoglycemia is common among individuals using insulin and oral
hypoglycemic, but hypoglycemia severe … records of those measurements of blood glucose with the patient
Obtain a history of all episodes of severe … Dehydration
Early in the disease, dehydration is less likely to cause severe metabolic issues. … With more severe diabetes, the ability to sense the
warning signs of frostbite, such as pain from prolonged … blood glucose) is common among individuals using insulin and oral
hypoglycemic, but hypoglycemia severe
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
October 01, 2017 - ulcers
OR Diagnosis of bleeding disorders
OR Diagnosis of renal failure (ESRD)
OR Diagnosis of severe
-
cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
02/08/2017
Time
1:30 – 3:30 PM ET
AGENDA
· Welcome
· Discuss Remaining Repository Questions
· Clarify 10-Year Risk Assessment Details
· Discuss Statin Therapy for the Prevention and Treatment of CVD eCQM/CDS Artifact
· Discuss Next Artifacts for Developmen…
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/CDSConnectPilotFinalReport508gel10012018.pdf
September 01, 2018 - CDS Connect Pilot Final Report Factors to Consider in Managing Chronic Pain: A Pain Management Summary
CDS Connect Pilot Final Report
Factors to Consider in Managing Chronic Pain:
A Pain Management Summary
Prepared for:
Agency for Healthcare Research and…
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
October 01, 2017 - Diagnosis of Active Cirrhosis added as an Exclusion
Statins are not indicated for individuals with severe … Cholesterol Management Work Group, an elevated ALT (i.e., > 3x's upper limit of normal or 150) can signify "severe
-
cds.ahrq.gov/sites/default/files/cds/artifact/logic/2024-08/USPSTFPrediabetesAndType2DiabetesPart1Screening_Change_Log.txt
January 01, 2024 - =========================================================================================
USPSTFPrediabetesAndType2DiabetesPart1Screening Change Log
=========================================================================================
The following CQL downloads are currently available on CDS Connect. Older
versio…
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
October 01, 2017 - CDS Connect Implementation Guide Draft
Agency for Healthcare Research and Quality (AHRQ)
Agency for Healthcare Research and Quality (AHRQ)
Implementation Guide
Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Hu…